>45% of this type of LQTS
63% of patients have cardiac events, typically triggered by exercise or emotional stress
Of Roman Ward syndromes, syncopy is the common in this one
Broad-based T waves on EKG
Mutation in KCNQ1 and KCNE1
Mutations lead to abnormal IKs potassium channel function
~40% of patients of this type of LQTS
46% have events usually triggered by exercise, emotional stress, or sleep
Events can, but not always, be triggered during sleep
Bifid T waves
Mutation in KCNH2 (HERG) and KCNE2
Mutations lead to abnormal IKr potassium channel function
Less that 10% of this type LQTS
18% have cardiac events
Long ST, small or biphasic T waves
Events triggered during sleep
Can only have a mutation in SCN5A, the sodium channel gene that causes abnormal INa channel function
Death is the first sign in 10-15%
Risk of sudden death from birth to age 40 is ~4% in each type
Genetic testing available for all 5 genes
75% of patients have a detectable mutation
Most common age of presentation is pre-teen years to 20s
Incidence is 1 in 7,000 in most populations
QT prolongation, T wave abnormalities, tachyarrhythmias including TdP
Most common symptom of this SYNDROME is syncope
50-70% of individuals with disease causing mutations have symptoms
Autosomal Recessive ONLY
Incidence is 1 to 6 per million
Deaf
Very long QTc
50% die by 15 years old if untreated
Homozygous for KCNQ1 (>90%)
Homozygous for KCNE1 (less than 10%)
Up to 50% are de novo mutations
Episodic flaccid muscle weakness (periodic paralysis)
Can have syndactyly, clinadactyly (5th finger toward 4th), short stature, scoliosis, hypertelorism, low set ears, and micrognathia
Mutation in KCNJ2
Mutation in inward rectifier potassium channel 2 protein
~60% have detectable mutation
Nearly all cases are new mutations
Syndactyly of fingers 2 through 5 and toes 2 and 3
Can have structural cardiac defects, HCM, dysmorphic facies, and neurologic abnormalities
Mutation in G406R
Affects calcium channel gene
Affects CACNA1C
Very rare disorder that causes LQTS
Rare disorder with high mortality in childhood
Prevalance is 1 in 10,000
Mean age of onset is 7 to 9
Syncope during exercise or acute emotion (besides RW)
Diagnosed by reprodible ventricular arrhythmias during stress testing
Heterozygous mutation in RARY2
Heterozygous mutation in 50 to 55% of patients
Homozygous mutation in 1 to 2%
Homozygous mutation in CASQ2
Incidence ranges from 5 to 66 per 10,000 in well sudied Asian populations
Common in Asian populations, less common in Europe and US
May be cause of 20% of sudden deaths in people with a normal looking heart
ST elevation in right precordial leads (V1 to V3)
RBBB in some patients
Events can be triggered during sleep (not RW)
EKG can be normal
Mutation in SCN5A (in some patients)
Only 20 to 25% of patients have a detectable mutation
Males are more commonly affected (8:1)
Average onset is 40 years
Range of onset is 2 days to 84 years
Presents with ventricular arrhythmias, at times lethal, particularly in the young and athletes
Mean age of diagnosis is 31 years, range 4 to 64 years
Autosomal dominant and recessive forms exist
Incidence of dominant form ranges from 6 in 10,000 to 4 in 1,000 in some areas
Most common cause of sudden cardiac death in young Italians
~17% of sudden death among young Americans
2 of these needed for diagnosis
4 needed for diagnosis
1 needed if have 2 of the other kind
Criteria: Severe RV dilation and reduction of RV function with mild or no LV impairment
Criteria: Localized RV aneurysms
Criteria: Severe segmental dilation of the RV
Criteria: Fibrofatty replacement of the myocardium on endomyocardial biopsy
Criteria: Epsilon waves
Criteria: Localized prolongation (>110 ms) of the QRS in the right precordial leads (V1 to V3)
Criteria: Positive family history, confirmed at autopsy or surgery
2 needed if have one of the other kind
Criteria: Mild global RV dilation and / or EF reduction with nomal LV
Criteria: Mild segmental dilation of the RV
Criteria: Regional RV hypokinesis
Criteria: Inverted T waves in right precordial leads (V2 and V3) (age >12 years) in absence of RBBB
Criteria: Frequent PVCs (>1,000 in 24 hours)
Criteria: LBBB-type V tach
Criteria: Family history of premature sudden death suspected to be caused by ARVD
Criteria: Positive family history of ARVD based on Task Force criteria
Parents and siblings should be screened by MRI or echo, EKG or molecular testing, if a mutation has been identified regardless if they have symptoms
Incomplete penetrance but asymptomatic individuals may still be at risk for later difficulties
Percentage of de novo mutations is unknown
Rare, also known as Naxos disease
Associated with dermatologic findings
Woolly hair
Palmoplantar keratoderma
Homozygous mutation in plakoglobulin
Mutation in gene affecting desmosomes and adherens junctions
Autosomal dominant, incidence ~1 in 500
Most common cause of death in youth in the US
~36% of sudden death in athletes under 35
Sudden death usually due to arrhytmias but patients may also die of stroke or progressive heart failure
Can result from mutation in 1 of 11 genes
Death can also be caused by stroke or progressive heart failure
Tentative association between ACE variants and extent of this disease
Modifier genes may affect expression of mutations
Is a disorder of the sarcomere
Some genotype-phenotype correlations have been identified but the impact of these on current therapy is unclear
Accurate classification if at-risk family members is the primary advantage of genetic testing in individual with a clinical diagnosis
Mutation in MYH7, presents in first 2 decades
MYH7 (B-myosin heavy chain gene) - most common gene mutation, ~35%
MYBP3 (myosin binding protein c, cardiac): occurs during 5th or 6th decades, 15% of gene causing mutations
TNNT (troponin 2, cardiac): less hypertrophy, more death, 15% of gene mutations
Resembles familial HCM, but distinguished by electrophysiological abnormalities
Can particularly be associated with ventricular preexcitation
2 types of dominant forms exist
What syndrome can have a lysosomal form
Mutation in LAMP2 (lysosomal associated membrane protein 2)
Cytoplasmic form is part of what syndrome?
Has cytoplasmic form with mutation in PRKAG2 (AMP-acitivated proten kinase g2)
Substantial proportion of CM not from sarcomere mutations
Mutation in LAMP2 (lysosomal associated membrane protein 2)
X-linked dominant subtype
Earlier age of onset and more severe course in males
Severe LV hypertophy and variable muscle weakness
Progressive conduction system defects, WPW, mentral retardation
This syndrome can have WPW
This subtype has a prognosis that is much worse than HCM
Elevated CK: X-linked dominant in this subtype
Patients who present in adolescense often die by early adulthood
Offspring of affected female have 50% chance of being affected
In affected males: daughters affected, sons not affected
Autosomal dominant, cytoplasmic subtype
Increased glycogen producation causes glycogen accumulation throughout the cardiomyocyte in this subtype
Compatible with long survival although pacemakers and aggressive treatment of arrhythmias may be required
25-50% of cases are familial
Autosomal dominant form has 2 broad categories: with and without conduction system disease
No specific clinical features distinguish between familial and nonfamilial forms
Younger patients are more likely to have familial disease
Elevated CK: X-linked recessive
Autosomal dominant form is most common
X-linked recessive form can occur
Autosomal recessive one of 4 forms
Mitochondreal inheritance form can occur
The autosomal dominant form accounts for ~90% of this disorder
17 autosomal dominant genes identified
None of the autosomal dominant genes account for more than 5 to 10% of disorder
X-linked form causes 5 to 10%
X-linked mutations: dystrophin and G4.5 / tafazzin
X-linked recessive mutation in dystrophin that also causes Duchenne and Becker MD
X-linked recessive mutation G4.5 / tafazzin also causes Barth syndrome and this disease +/- non-compaction
The autosomal recessive form of this if more like to occur in certain ethnic groups or consanguinity and is very rare
The only gene linked to the AR form of this is troponin I
Mitochondrial point mutations and deletions; cause multiorgan system disease
Mitochondrial form of this is part of